[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-LBRX":3,"stock-news-LBRX":31,"homepage-market-summary":84},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"LBRX","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"LB Pharmaceuticals Inc Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and other diseases. It is building a pipeline that leverages the broad therapeutic potential of its product candidate, LB-102, which it believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is currently in late-stage clinical development for schizophrenia and bipolar depression. The company operates as a single reportable segment in the development of novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia.","27","New York, NY",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},34.62,36.41,36.88,34.47,36.99,-2.37,-6.41,492364.483768,9165,35.2858,50.16,14.317,272232.57435086457,56.6,268,{"ticker":4,"count":32,"articles":33},9,[34,40,45,51,57,63,69,74,79],{"title":35,"link":36,"pubDate":37,"description":38,"source":39},"LB Pharmaceuticals Inc (NASDAQ:LBRX) Stock Rated \"Moderate Buy\" by Sell-Side Analysts - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi3gFBVV95cUxQblotanlYb3FHU3d1R1NCQ3A2bEZaODNPQ0FHQlpyQlVFMVJYNl9PaTd3YW0wWHZJVnVHZ1lxQ050S0tUMlVBNEV0bEVEdWtpQjA4NnVkX1VSSzIxNVE4RW8wMmRHeXQ1ZkI3Q3AyVW53ZTRXM01lLVppUndfQVN6WWJnUFI1YkpHWG9pOEVrdFZVSEpZYnZDUjRwUkIwSEpiQkhJMGhPRXg1LWV6ejRkQkxMVWg2bXZlbTdSWVk2eEtQZXNLVFh6Q2tyTEczMFRJLXV3VkhqUWVWWEJuVEE?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","LB Pharmaceuticals Inc (NASDAQ:LBRX) Stock Rated \"Moderate Buy\" by Sell-Side Analysts MarketBeat","MarketBeat",{"title":41,"link":42,"pubDate":43,"description":44,"source":39},"LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Down 5.4% Following Analyst Downgrade - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi1AFBVV95cUxNR0h5ckJfTjZMbl9NbThWSGFFTnQzUFJwVFJJTkJ0RW1yMGVQMWVoOG5ReUtKaEd0VTFhbHhBcFBWaW40TzlaRDcxR2RmcHJqV1pqUWhBU0NZRW50aXRpYVhxRXF0TUpHaDh0LWNCUU9iMlJYdkdySVdiNmFfaXpLdlpLM1psX1lWcTdUSmY0U0xjMEpiQVZBdng2QXJaY0x4bHBlb1lQSnB6aE9oMnhfeXo0T2FWNnNoeE11QnlYaEVfRWNNelJwZmJRRG1TdFladFpaeg?oc=5","Mon, 05 Oct 2026 19:47:31 GMT","LB Pharmaceuticals (NASDAQ:LBRX) Stock Price Down 5.4% Following Analyst Downgrade MarketBeat",{"title":46,"link":47,"pubDate":48,"description":49,"source":50},"Needham initiates LB Pharmaceuticals stock with buy rating - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxNUGQ0b2tZNE5qZklRUVJxNTJwTG5ReWJMVVlzZDY4bGZQTVpyaFAwS3hHYXEwWGYwcDBzWGtOa09wSndoS1RpemNURnpnb0hpMzh3SGNkQmViMmFUV1lFUzB1ai1zcmV2THI4RXBLbXVjNmNTT0s1Z3Bfb1lORlp6eHcwTlpIemF1VjNhTnNhX2hOUC1PMkN1M1lKTm1Sd3RFc0JKdDdrUzhTeFhDMkxQUG9WNTRLb1pJa3c?oc=5","Fri, 02 Oct 2026 09:43:38 GMT","Needham initiates LB Pharmaceuticals stock with buy rating Investing.com","Investing.com",{"title":52,"link":53,"pubDate":54,"description":55,"source":56},"Needham initiates coverage of LB Pharmaceuticals with Buy rating, $68 price target - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2gFBVV95cUxPWk05MXRjNXRNOHJoc29UM2R5TnBfckd3SXFheFNwRG1FSmg3V1ZoNVczcjVlV2lWSGtzWmhHUVEwdVNHbUxhY3ZJR1ZlUWpIeXctaGFPdHY4a2NmVldEMU9hRjJOUmpTQUgtOW1wSUFEdERCakVlTTlfRTNCTm95N205OFBTRXgyMWRlSUpKSkxpVUtqdjJFbEpoRGNXOFNqX012RFg2R09IYTFnbmxGNk56YlFIbDNCQ2poWTVCQTVsY0NWcGFDUWFEdUZrZXZOMzFWbW43T28wQQ?oc=5","Fri, 02 Oct 2026 09:18:31 GMT","Needham initiates coverage of LB Pharmaceuticals with Buy rating, $68 price target TradingView","TradingView",{"title":58,"link":59,"pubDate":60,"description":61,"source":62},"This Enliven Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiigJBVV95cUxNZVI3R1RPaEl4SnRiTk1WaTRIZG9ZZTR6MmljUFQ5bmJKZFpxNTQyT1BCVkJzUDFRVmpDVVF1cE4yMzE1U0xrV0ZESG1KeUk1dlYtMFRpQ3lzeGJpV1BSa1EyOVpiRnMyQkp4MW1vWmRXR3ZNbzR2WHZzUE1oWk1iaDV0dlRVMkZzLUQzMFJOdms5N3JmWWs0VXRYQ0FCaUhZVzlSWDhjeU1McVlRMndrbEcwUHlYbmhLdC1MX1NIV3ZXTWs3Tk5kRzNaZVlldmRwYXE1bmhkRFB0eWhUc0g5b1Rzb0pUd0tROUxXM2E3TmM2ckdGamN6aGI1TFpVOWVaSHFZVGl6aVg3Zw?oc=5","Fri, 02 Oct 2026 12:24:05 GMT","This Enliven Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Benzinga","Benzinga",{"title":64,"link":65,"pubDate":66,"description":67,"source":68},"Roth\u002FMKM Downgrades LB Pharmaceuticals Inc (LBRX) to Neutral - StreetInsider","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxOQ0ZLZ0NnNmFoTTVkcWFrRDZ6cjllemJzS1dUWVlXWS1RWFQ3aFkwNURpelU5Rlo0eWdWQ0NRMWExWmp5RWlVM2ZoSXdxTUFYTVY2MzJRejNyak5iVWNIOGpUSWh4OGh1bE1mYkotYUNJa2VXUmN2elNyY0xYelBOeDl1Z2ZkUW16R3FuSHBaSEMtWUptaXM0ZVkyQlhlYVJHVFg1dVB5cm1vdHB6QjJRZkJnSUxuRnNXSlE?oc=5","Mon, 05 Oct 2026 14:23:22 GMT","Roth\u002FMKM Downgrades LB Pharmaceuticals Inc (LBRX) to Neutral StreetInsider","StreetInsider",{"title":70,"link":71,"pubDate":72,"description":73,"source":39},"LB Pharmaceuticals (NASDAQ:LBRX) Rating Lowered to \"Strong Sell\" at Wall Street Zen - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2AFBVV95cUxQS2lPMzVQZlFDdlhlanh3cHliRnpjdVlqNVQ2anZadHN3cGZhaUZCQ0dkX0xLOE41RG1HXzYtSllNMGRDMWV0Y3NhMmlRSlNIY1VBVjlJRUh6M1ZYWVFUcXkzTkNkYVNYZ0tpaF9wakJCQ0lEUzNpNjN6X3FmanZ0ZWtUNExSb1JPM1VKMWdRUHZia2x0WjViX2pXbU14MEdaLW9YRkxYckV0Y1NNejVCUF85ajd4NmVYZXdubWs3ejltZXJBRkczdnJhcHdISm44T054T0xGUnI?oc=5","Sat, 03 Oct 2026 05:51:07 GMT","LB Pharmaceuticals (NASDAQ:LBRX) Rating Lowered to \"Strong Sell\" at Wall Street Zen MarketBeat",{"title":75,"link":76,"pubDate":77,"description":78,"source":39},"Needham & Company LLC Upgrades LB Pharmaceuticals (NASDAQ:LBRX) to \"Moderate Buy\" - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0wFBVV95cUxOX0ZJbDBJQ245eTBKOTJTLVpCZzg2WUs0MnNVdV9yZEp4RnloSXhoSU9MRVRnZm5zc1oxLXhJNGRYU2NMNWVlVkZYeDBqaWYzbWIxYllueXhPTjNsOWJfS2xWS21yeTh2bmlGY3c5WUZlZnhIS1VVNzhQcWtlaG5ybmVCWVlIM1dwMG5Eb05MQVNSRktBTFYtVjBCbGNYYlBUeEN2MlRVRTAwTjhwYlFBUWZlOFpyYktydTk4RmNlRHN3X0ZDRjVZODAxVkN5QXB5TlZR?oc=5","Sat, 03 Oct 2026 10:05:23 GMT","Needham & Company LLC Upgrades LB Pharmaceuticals (NASDAQ:LBRX) to \"Moderate Buy\" MarketBeat",{"title":80,"link":81,"pubDate":82,"description":83,"source":39},"LB Pharmaceuticals (NASDAQ:LBRX) Rating Lowered to \"Neutral\" at Roth Capital - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizwFBVV95cUxPRmRFbnpjSExCaEpnSjhzWkVlVDUxUzRUZU5sM2ZPbVVIV1NiejY4dDhlci05X2VjZFMwMGhUYnlJTHhMQm9iUkVoNXNKTmZiZHcwN3Fua3MxeTAwcl9kRXBpWHItQ2lyWEtwS211dk9UUEthYkdJRml1Y19ja0NsNzRFb3R5Y1llZ0ZPbmo4S3hQOG5IbW11bWhBdEpGdk1RWlJtNTZEX3RMMVk0VXlodnNSUUFNLVpqQ002eHc3OGpPOHZ1VHNpNDhoRm1WZ1U?oc=5","Mon, 05 Oct 2026 13:18:32 GMT","LB Pharmaceuticals (NASDAQ:LBRX) Rating Lowered to \"Neutral\" at Roth Capital MarketBeat",{"status":85,"indices":86,"watchlist":129,"sectors":151,"benchmarks":206},"success",[87,95,102,109,116,122],{"symbol":88,"name":89,"price":90,"change":91,"pct_change":92,"is_up":93,"sparkline":94,"date":5},"SPX","S&P 500",7773.95,51.23,0.66,true,"0.0,8.3 2.3,10.7 4.6,13.5 6.9,9.4 9.3,11.7 11.6,13.9 13.9,16.0 16.2,10.6 18.5,9.8 20.8,2.6 23.2,2.6 25.5,6.3 27.8,6.4 30.1,3.9 32.4,7.7 34.7,8.5 37.1,9.7 39.4,8.8 41.7,5.2 44.0,2.0",{"symbol":96,"name":97,"price":98,"change":99,"pct_change":100,"is_up":93,"sparkline":101,"date":5},"NDX","NASDAQ 100",31076.44,268.51,0.87,"0.0,12.3 2.3,12.8 4.6,14.9 6.9,13.2 9.3,14.8 11.6,16.0 13.9,16.0 16.2,12.7 18.5,11.4 20.8,5.9 23.2,4.3 25.5,6.0 27.8,5.9 30.1,5.1 32.4,7.2 34.7,6.8 37.1,6.4 39.4,5.8 41.7,3.8 44.0,2.0",{"symbol":103,"name":104,"price":105,"change":106,"pct_change":107,"is_up":93,"sparkline":108,"date":5},"DJI","DOW JONES",51268,91,0.18,"0.0,2.0 2.3,5.0 4.6,7.4 6.9,3.6 9.3,4.7 11.6,7.2 13.9,11.9 16.2,9.5 18.5,10.2 20.8,7.5 23.2,8.9 25.5,11.5 27.8,12.7 30.1,9.1 32.4,11.7 34.7,12.7 37.1,16.0 39.4,15.8 41.7,14.0 44.0,13.3",{"symbol":110,"name":111,"price":112,"change":113,"pct_change":114,"is_up":93,"sparkline":115,"date":5},"COMP","NASDAQ Composite",27477.31,286.45,1.05,"0.0,11.9 2.3,13.4 4.6,15.0 6.9,12.7 9.3,14.1 11.6,16.0 13.9,16.0 16.2,11.9 18.5,10.9 20.8,5.3 23.2,4.2 25.5,7.1 27.8,7.0 30.1,5.8 32.4,8.1 34.7,8.3 37.1,7.8 39.4,7.7 41.7,4.7 44.0,2.0",{"symbol":117,"name":118,"price":119,"change":120,"pct_change":92,"is_up":93,"sparkline":121,"date":5},"RUT","RUSSELL 2000",2833.8,18.6,"0.0,2.0 2.3,5.4 4.6,7.8 6.9,6.8 9.3,8.3 11.6,10.0 13.9,11.0 16.2,9.7 18.5,10.8 20.8,9.6 23.2,8.2 25.5,12.6 27.8,12.9 30.1,12.6 32.4,14.2 34.7,15.1 37.1,16.0 39.4,15.1 41.7,13.0 44.0,11.4",{"symbol":123,"name":124,"price":125,"change":126,"pct_change":127,"is_up":93,"sparkline":128,"date":5},"VIX","CBOE VIX",15.52,0.21,1.37,"0.0,10.2 2.3,7.3 4.6,2.0 6.9,9.7 9.3,4.9 11.6,4.5 13.9,2.5 16.2,11.3 18.5,13.7 20.8,13.5 23.2,16.0 25.5,12.3 27.8,10.4 30.1,13.5 32.4,8.8 34.7,8.9 37.1,7.8 39.4,7.6 41.7,11.8 44.0,10.9",[130,137,144],{"symbol":131,"name":132,"price":133,"change":134,"pct_change":135,"is_up":93,"sparkline":136,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":138,"name":139,"price":140,"change":141,"pct_change":142,"is_up":14,"sparkline":143,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":145,"name":146,"price":147,"change":148,"pct_change":149,"is_up":93,"sparkline":150,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[152,157,162,167,172,177,182,187,192,197,201],{"name":153,"etf":154,"change":155,"price":156,"is_up":93},"Technology","XLK",0.56,200.93,{"name":158,"etf":159,"change":160,"price":161,"is_up":93},"Financials","XLF",0.73,53.88,{"name":163,"etf":164,"change":165,"price":166,"is_up":93},"Healthcare","XLV",0.72,167.37,{"name":168,"etf":169,"change":170,"price":171,"is_up":93},"Consumer Cycl","XLY",0.35,110.42,{"name":173,"etf":174,"change":175,"price":176,"is_up":93},"Consumer Staples","XLP",0.63,81.04,{"name":178,"etf":179,"change":180,"price":181,"is_up":93},"Energy","XLE",0.99,63.44,{"name":183,"etf":184,"change":185,"price":186,"is_up":93},"Industrials","XLI",0.09,170.1,{"name":188,"etf":189,"change":190,"price":191,"is_up":93},"Materials","XLB",1.31,49.5,{"name":193,"etf":194,"change":195,"price":196,"is_up":14},"Real Estate","XLRE",-0.34,40.67,{"name":198,"etf":199,"change":170,"price":200,"is_up":93},"Utilities","XLU",39.97,{"name":202,"etf":203,"change":204,"price":205,"is_up":93},"Comm Services","XLC",1.17,111.61,[207,212,217,222],{"ticker":208,"name":209,"price":210,"change":211,"is_up":93},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":213,"name":214,"price":215,"change":216,"is_up":93},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":218,"name":219,"price":220,"change":221,"is_up":93},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":223,"name":224,"price":225,"change":92,"is_up":93},"IWM","iShares Russell 2000",283.39]